Tzetzo, Stephanie L.
Schultz, Emily
Wang, Jianxin
Rosenheck, Hanna R.
Mahan, Sidney
Knudsen, Erik S.
Witkiewicz, Agnieszka K.
Funding for this research was provided by:
National Cancer Institute (R01CA247362, R01CA247362)
Roswell Park Alliance Foundation
Article History
Received: 7 February 2025
Accepted: 20 May 2025
First Online: 12 June 2025
Competing interests
: E.S.K.: Sponsored research funded by Blueprint Medicines and Bristol Myers Squibb. Member of the Cancer Cell Cycle-LLC consulting enterprise. A.K.W.: Sponsored research funded by Blueprint Medicines and Bristol Myers Squibb. The other authors declare no competing interests.